NEWS
AstraZeneca praises UAE for vaccination rollout and testing strategy “Specifically, the UAE ranks among the best in the world in terms of the speed of its vaccination programme. This is attributed to strong efforts from key senior stakeholders who worked collaboratively with health authorities to deliver impactful campaigns that are aimed at increasing the trust in the safety of vaccines available in the country, and uptake from the local population,” added Al Manaseer. The comments were made ahead of the inaugural Pharma and Drug Discovery Conference were held on the opening day of Arab Health, which took place from 21-24 2021 June at the Dubai World Trade Centre. During the conference, Mr Al Manaseer presented the session Oxford University and AstraZeneca partnership towards broad and equitable access to COVID-19 Vaccine.
To date, over 12.1 million vaccination doses have been administered in the UAE with a vaccine distribution rate of over 124 doses per 100 people, with approximately 70,000 doses of the vaccine administered daily. In terms of population vaccinated, the UAE is currently fourth after the Seychelles, Maldives and Israel.
"From the start of the pandemic, AstraZeneca's approach has focused on partnering with scientists, governments, multilateral organisations and manufacturers to establish agreements for the development and supply of our vaccine, and to fight the pandemic, together,” said Al Manaseer. “At AstraZeneca, we were proud to be the first global pharmaceutical company to join COVAX in June 2020. Through the initiative, we are partnering with CEPI, Gavi, the WhO, UNICEF and PAHO and our subscribing partner, the Serum Institue of India, to enable equitable and global access to our vaccine. Together, we have already delivered 37 million doses of our vaccine, including critical deliveries to countries in the Middle East. It is only through effective partnerships that reaching these milestones was made possible," he added.
Qutaiba Al Manaseer, Government Affairs Director, Middle East and Africa, AstraZeneca, said: Middle East countries have been successful in their efforts to make vaccines available as soon as possible. Health authorities across the region have developed agile regulatory systems and adapted rolling review strategies to ensure a fast but thorough regulatory process.
Among the experts presenting at the Pharma & Drug Discovery Conference, are Dr Yang Xiaoming, Chairman of the China National Biotech Group (CNBG), Prof Graham Ball, Professor of Bioinformatics, Nottingham and Trent University, UK, and Prof Mirza Baig, Professor and Chairman of Clinical Pharmacy and Pharmacotherapeutics, Dubai Pharmacy College for Girls.
Qutaiba Al Manaseer
A
Government Affairs Director from AstraZeneca, the developer of one of the leading COVID-19 vaccines in partnership with Oxford University, has praised the UAE’s vaccine rollout program by highlighting the work done by health authorities in the region to make vaccines available as soon as possible.
JULY.AUG 2021
30
ASTRAZENECA HAS APPLAUDED THE UAE’S IMPACTFUL VACCINATION CAMPAIGNS WHICH HAS CREATED INCREASED TRUST AND EARLY UPTAKE RESULTING IN OVER 12.1 MILLION DOSES IN THE UAE TO DATE.
TO DATE, OVER 12.1 MILLION VACCINATION DOSES HAVE BEEN ADMINISTERED IN THE UAE WITH A VACCINE DISTRIBUTION RATE OF OVER 124 DOSES PER 100 PEOPLE, WITH APPROXIMATELY 70,000 DOSES OF THE VACCINE ADMINISTERED DAILY.
